Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8211846 | International Journal of Radiation Oncology*Biology*Physics | 2017 | 22 Pages |
Abstract
Prostate-specific membrane antigen PET demonstrated a large number of otherwise unknown metastatic lesions. Therefore we recommend PSMA PET for more accurate assessment of disease burden in initial staging of high-risk PC, as well as for restaging in patients with prostate-specific antigen relapse after primary therapies. Furthermore, a high proportion of oligometastases on PSMA PET provides a prime opportunity to investigate the role of targeted local therapies for oligometastatic PCs.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Sandeep K. FRACP, Tahne BAppSci (MRT), Jim FRANZCR, Thomas P. MBBS, MPH, FRANZCR, FAMS, Grad Dip Med (Clin Epi), Natalie FRACP, Nicholas BSc, BMed(Hons), FRACS, Kevin BMRS, Paul MBChB, FRACS, Tony FRACP, Jarad M. MBChB, BSc, PhD, DMed, FRANZCR, GAustMS,